Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN111235084A reveals a cost-effective enzymatic route for S-adenosylmethionine using recombinant E. coli, offering significant supply chain advantages.
Patent CN104480100A reveals immobilized enzyme method for L-tert-leucine. Offers high conversion, enzyme reuse, and cost reduction for pharmaceutical supply chains.
Patent CN112707876A details a gradient temperature method for HBPA glycidyl ether, offering low chlorine content and superior weather resistance for industrial epoxy applications.
Patent CN108295882B reveals a magnetic core-shell Pd catalyst for efficient Tinib intermediate production, offering reduced metal residues and enhanced recyclability for pharmaceutical manufacturing.
Novel Yarrowia lipolytica enzyme method for PGF 2α production. Green synthesis ensures high purity and scalable supply chain solutions for global pharmaceutical intermediates manufacturing.
Advanced catalytic synthesis of Cefazedone via patent CN110563750B. Delivers high-purity antibiotic intermediates with simplified processing and superior supply chain reliability.
Patent CN102010282B reveals a green aqueous method for diaryl disulfide production. Achieve significant cost reduction in fine chemical manufacturing with scalable technology.
Patent CN105732663B reveals a novel activator boosting 6-APA yield. Enhances supply chain reliability and reduces manufacturing costs for pharmaceutical intermediates.
Patent CN102731478A details a high-yield asymmetric oxidation route for Dexlansoprazole intermediates, offering superior optical purity and scalable manufacturing capabilities for global supply chains.
Patent CN120535435A reveals a safer two-phase synthesis for crisaborole intermediates, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturers.
Novel visible-light method using 4CzIPN for high-purity sulfone intermediates. Reduces cost and simplifies supply chain for pharma manufacturing.
Patent CN103467282A details a mild, iridium-catalyzed visible light method for synthesizing polysubstituted naphthols, offering significant cost reduction and supply chain reliability for pharmaceutical intermediates.
Patent CN101824052A details a mild NHC-metal complex catalyzed method for phosphine synthesis, offering cost reduction in fine chemical manufacturing and high-purity ligand production.
Patent CN102010341A reveals Ni-B catalyst method for 4-aminodiphenamine. Reduces costs and waste versus noble metal processes for rubber additive manufacturing.
Patent CN118063351B reveals immobilized enzyme process for high-purity chiral beta-amino acids, offering cost reduction and supply chain reliability for pharmaceutical manufacturing.
Advanced enzymatic synthesis of levocarnitine via patent CN118879801B offers high yield and supply chain stability for global pharmaceutical manufacturers.
Patent CN111479795A details a high-yield process for dialkyl ethers using metallic sodium and monoether-monoalcohol catalysts, offering significant cost and safety advantages.
Patent CN114890908B reveals a catalytic method for gamma-trifluoromethyl amino acids using Togni reagents, offering cost reduction in API manufacturing and scalable production.
Patent CN100554403C reveals Microbacterium oxydans for high-purity chiral alcohol. Offers cost reduction and supply chain reliability for pharma intermediates.
Novel 5-step synthesis route for entecavir intermediate offers high yield and scalable production for pharmaceutical supply chains.